✦ LIBER ✦

N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma

✍ Scribed by Carlo Riccardo Rossi; Simone Mocellin; Sandro Pasquali; Pierluigi Pilati; Donato Nitti

Book ID: 111772244
Publisher: Springer
Year: 2007
Tongue: English
Weight: 259 KB
Volume: 15
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-007-9641-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

45 ORAL “N-ratio” as a novel prognostic

45 ORAL “N-ratio” as a novel prognostic factor for patients with stage III cutaneous melanoma

✍ C.R. Rossi; S. Mocellin; L.G. Campana; S. Pasquali; M. Foletto; M. Lise; D. Nitt 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Lymph node ratio is an important and ind

Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma

✍ Adam C. Berger; Michael Fierro; John C. Kairys; David Berd; Takami Sato; Jocelyn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

QS333. Lymph Node Ratio Is an Important

QS333. Lymph Node Ratio Is an Important and Independent Prognostic Factor for Patients With Stage III Malignant Melanoma

✍ M. Fierro; J.C. Kairys; M.J. Mastrangelo; D. Berd; T. Sato; E. Pequignot; T. Hys 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Sarcopenia as a Prognostic Factor among

Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma

✍ Michael S. Sabel; Jay Lee; Shijie Cai; Michael J. Englesbe; Stephen Holcombe; St 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 413 KB

Prognostic variables for patients with s

Prognostic variables for patients with stage III malignant melanoma

✍ G. E. Messaris; M. M. Konstadoulakis; N. Ricaniadis; E. Leandros; G. Androulakis 📂 Article 📅 2000 🏛 Taylor and Francis Group ⚖ 49 KB

Adjuvant high-dose interferon for cutane

Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease

✍ Daniel A. Anaya; Yan Xing; Lei Feng; Xuelin Huang; Luis H. Camacho; Merrick I. R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract ## BACKGROUND. Evidence from randomized trials in the pre‐sentinel lymph node biopsy era indicate that adjuvant treatment with high‐dose interferon‐α (IFN) increases recurrence‐free survival (RFS) in patients with high‐risk melanoma. However, to the authors' knowledge, the role of this